These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10500580)

  • 1. The double or single renal graft depending on the percentage of glomerulosclerosis in the preimplant biopsy reduces the number of discarded kidneys from donors older than 60 years.
    Andrés A; Herrero JC; Morales E; Praga M; Vázquez S; Vereda M; Cebrián P; Rodicio JL; Morales JM; Aguirre F; Diaz R; Polo G; Leiva O
    Transplant Proc; 1999 Sep; 31(6):2285-6. PubMed ID: 10500580
    [No Abstract]   [Full Text] [Related]  

  • 2. Double versus single renal allografts from aged donors.
    Andrés A; Morales JM; Herrero JC; Praga M; Morales E; Hernández E; Ortuño T; Rodício JL; Martínez MA; Usera G; Díaz R; Polo G; Aguirre F; Leiva O
    Transplantation; 2000 May; 69(10):2060-6. PubMed ID: 10852597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanded criteria donor kidneys where the paired kidney is discarded owing to biopsy results: a concept that needs revision.
    Bodzin AS; Leiby BE; Ramirez CB; Frank AM; Doria C
    Exp Clin Transplant; 2014 Dec; 12(6):499-505. PubMed ID: 25489800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of proteinuria in cyclosporine-treated cadaveric renal transplant recipients.
    Koay HC; Vathsala A; Woo KT
    Transplant Proc; 2000 Nov; 32(7):1921-3. PubMed ID: 11120001
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute rejection episodes predict long-term renal transplantation survival.
    Kokado Y; Takahara S; Hatori M; Ichimaru I; Wang JD; Miki T; Okuyama A
    Transplant Proc; 1997; 29(1-2):1537-40. PubMed ID: 9123416
    [No Abstract]   [Full Text] [Related]  

  • 6. Accelerated acute rejection in renal allograft.
    Han DJ; Yoon HS; Lee HM
    Transplant Proc; 1996 Jun; 28(3):1455. PubMed ID: 8658738
    [No Abstract]   [Full Text] [Related]  

  • 7. Outcome of renal transplantation from elderly donors.
    Bilgin N; Karakayali H; Moray G; Demirağ A; Arslan G; Akkoç H; Turan M
    Transplant Proc; 1998 May; 30(3):744-6. PubMed ID: 9595081
    [No Abstract]   [Full Text] [Related]  

  • 8. Tacrolimus as a primary immunosuppressive therapy in cadaveric renal transplantation: five years' experience at a single center.
    Schneeberger H; Zanker B; Hillebrand G; Illner WD; Rothenpieler U; Land W
    Transplant Proc; 1998 Jun; 30(4):1598-9. PubMed ID: 9636642
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term outcome of kidney transplantation from expanded criteria donors: a single center experience.
    Golconda MS; Whiting JF; Smith R; Hayes R; Alexander JW; First MR
    Transplant Proc; 1997 Dec; 29(8):3379-81. PubMed ID: 9414756
    [No Abstract]   [Full Text] [Related]  

  • 10. The prognostic utility of deceased donor implantation biopsy in determining function and graft survival after kidney transplantation.
    Cockfield SM; Moore RB; Todd G; Solez K; Gourishankar S
    Transplantation; 2010 Mar; 89(5):559-66. PubMed ID: 20110855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The LifeLink Foundation and cadaver kidney transplantation in Tampa.
    LeFor WM; Wright CE; Bowers VD; Heinrichs DF; Shires DL
    Clin Transpl; 1999; ():149-58. PubMed ID: 11038633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deceased donor organ transplantation with expanded criteria donors: a single-center experience from India.
    Goplani KR; Firoz A; Ramakrishana P; Shah PR; Gumber MR; Patel HV; Vanikar AV; Trivedi HL
    Transplant Proc; 2010; 42(1):171-4. PubMed ID: 20172307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simulect (basiliximab) reduces acute cellular rejection in renal allografts from cadaveric and living donors.
    Mulloy LL; Wright F; Hall ML; Moore M
    Transplant Proc; 1999; 31(1-2):1210-3. PubMed ID: 10083541
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunosuppression for recipients of kidneys from non-heart-beating donors: comparison of triple therapy and OKT3 regimens.
    Kehinde EO; Wheatley T; Feehally J; Nicholson ML; Veitch PS; Bell PR
    Transplant Proc; 1996 Jun; 28(3):1338-9. PubMed ID: 8658684
    [No Abstract]   [Full Text] [Related]  

  • 15. Outcome of cadaver kidneys using nonideal donors.
    Madden RL; Munda R; Hariharan S; Alexander JW; First MR
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1568-9. PubMed ID: 8442193
    [No Abstract]   [Full Text] [Related]  

  • 16. Kidney transplantation from older ( > or = 55 years) donors: a risk factor for graft survival.
    Mizutani K; Katoh N; Yamada S; Ono Y; Takeuchi N; Matsuura O; Ohshima S
    Transplant Proc; 1996 Jun; 28(3):1589-90. PubMed ID: 8658797
    [No Abstract]   [Full Text] [Related]  

  • 17. Cadaveric renal transplantation at University Hospital Kuala Lumpur: a preliminary report.
    Tan SY; Chen TP; Lee SH; Tan PS; Chua CT; Teo SM; Thiruventhiran T; Wo M; Loh CS; Hassan A; Tan JC; Koh SN
    Transplant Proc; 2000 Nov; 32(7):1811-2. PubMed ID: 11119947
    [No Abstract]   [Full Text] [Related]  

  • 18. Current advantage of FK 506 in cadaveric kidney transplantation.
    Ciancio G; Rosen A; Loreto-Grand B; Burke G; Siquijor A; Luque C; Esquenazi V; Miller J
    Transplant Proc; 1996 Apr; 28(2):1000-1. PubMed ID: 8623207
    [No Abstract]   [Full Text] [Related]  

  • 19. Living unrelated kidney transplantation.
    Malaise J; Mourad M; Besse T; Jamar F; Baldi A; Setola P; De Meyer M; Pirson Y; Squifflet JP
    Transplant Proc; 1997 Nov; 29(7):2770-2. PubMed ID: 9365556
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of HLA semi-identical pretransplant blood transfusions on renal allograft outcome.
    Mariat C; Alamartine E; De Filippis JP; Deprele C; Le Petit JC; Goure D; Berthoux F
    Transplant Proc; 2000 Mar; 32(2):381-3. PubMed ID: 10715446
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.